Article
Kallikreins as Biomarkers for Prostate Cancer
1 Jan 2014
Abstract excerpt
The introduction of testing for prostate-specific antigen (PSA), a member of the fifteen-gene family of kallikrein-related peptidases and also known as kallikrein-related peptidase 3 (KLK3), in blood has revolutionized both the detection and management of prostate cancer. Given the similarities between PSA and other KLK gene family members along with limitations of PSA as a biomarker for prostate cancer mainly in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
